Boston Scientific (BSX) Likely to Lower Guidance - Needham & Company

April 16, 2019 1:06 PM EDT Send to a Friend
Needham & Company analyst Mike Matson reiterated a Strong Buy rating and $43.00 price target on Boston Scientific (NYSE: BSX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login